Aier Eye Hospital Group (300015) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aier Eye Hospital Group (300015) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.69 Billion ≈ $246.85 Million USD) by net assets (CN¥23.82 Billion ≈ $3.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300015 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Aier Eye Hospital Group - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Aier Eye Hospital Group's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Aier Eye Hospital Group Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aier Eye Hospital Group ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
A.P.MOELL-M.B U.ADR 1/200
F:DP4H
|
0.044x |
|
Var Energi ASA
OL:VAR
|
36.298x |
|
Wuxi Lead Auto Equipment Co Ltd
SHE:300450
|
0.119x |
|
VERBUND AG
VI:VER
|
0.039x |
|
WinWay Technology Co. Ltd
TW:6515
|
0.020x |
|
Revvity Inc.
NYSE:RVTY
|
0.016x |
|
Hyundai Glovis
KO:086280
|
0.084x |
|
Shenzhen Kinwong Electronic Co Ltd
SHG:603228
|
0.030x |
Annual Cash Flow Conversion Efficiency for Aier Eye Hospital Group (2006–2025)
The table below shows the annual cash flow conversion efficiency of Aier Eye Hospital Group from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Aier Eye Hospital Group worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥23.40 Billion ≈ $3.42 Billion |
CN¥5.97 Billion ≈ $874.00 Million |
0.255x | +14.05% |
| 2024-12-31 | CN¥21.81 Billion ≈ $3.19 Billion |
CN¥4.88 Billion ≈ $714.34 Million |
0.224x | -23.68% |
| 2023-12-31 | CN¥20.02 Billion ≈ $2.93 Billion |
CN¥5.87 Billion ≈ $859.24 Million |
0.293x | +15.03% |
| 2022-12-31 | CN¥17.62 Billion ≈ $2.58 Billion |
CN¥4.49 Billion ≈ $657.13 Million |
0.255x | -23.70% |
| 2021-12-31 | CN¥12.22 Billion ≈ $1.79 Billion |
CN¥4.08 Billion ≈ $597.63 Million |
0.334x | +6.44% |
| 2020-12-31 | CN¥10.65 Billion ≈ $1.56 Billion |
CN¥3.34 Billion ≈ $489.28 Million |
0.314x | +6.06% |
| 2019-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
CN¥2.08 Billion ≈ $304.14 Million |
0.296x | +26.20% |
| 2018-12-31 | CN¥5.97 Billion ≈ $873.46 Million |
CN¥1.40 Billion ≈ $204.85 Million |
0.235x | -3.54% |
| 2017-12-31 | CN¥5.47 Billion ≈ $800.73 Million |
CN¥1.33 Billion ≈ $194.68 Million |
0.243x | +15.57% |
| 2016-12-31 | CN¥3.21 Billion ≈ $469.58 Million |
CN¥675.10 Million ≈ $98.79 Million |
0.210x | +0.69% |
| 2015-12-31 | CN¥2.50 Billion ≈ $365.71 Million |
CN¥522.17 Million ≈ $76.41 Million |
0.209x | -5.07% |
| 2014-12-31 | CN¥2.06 Billion ≈ $301.63 Million |
CN¥453.68 Million ≈ $66.39 Million |
0.220x | -7.26% |
| 2013-12-31 | CN¥1.74 Billion ≈ $254.44 Million |
CN¥412.65 Million ≈ $60.38 Million |
0.237x | +23.36% |
| 2012-12-31 | CN¥1.57 Billion ≈ $229.58 Million |
CN¥301.82 Million ≈ $44.17 Million |
0.192x | +5.75% |
| 2011-12-31 | CN¥1.41 Billion ≈ $206.81 Million |
CN¥257.11 Million ≈ $37.62 Million |
0.182x | -0.79% |
| 2010-12-31 | CN¥1.31 Billion ≈ $191.49 Million |
CN¥239.97 Million ≈ $35.11 Million |
0.183x | +33.78% |
| 2009-12-31 | CN¥1.23 Billion ≈ $180.56 Million |
CN¥169.14 Million ≈ $24.75 Million |
0.137x | -70.36% |
| 2008-12-31 | CN¥261.99 Million ≈ $38.34 Million |
CN¥121.17 Million ≈ $17.73 Million |
0.463x | +15.81% |
| 2007-12-31 | CN¥230.83 Million ≈ $33.78 Million |
CN¥92.19 Million ≈ $13.49 Million |
0.399x | +62.31% |
| 2006-12-31 | CN¥149.98 Million ≈ $21.95 Million |
CN¥36.90 Million ≈ $5.40 Million |
0.246x | -- |
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and p… Read more